EUVIMEDEUVIMED entdecken
Crossref

Impact of Persistent Left Superior Vena Cava on Outcomes With Atrial Fibrillation Ablation

Claire Sorensen iD, Ahmed Shahab, Jinxiang Hu, Raghu Dendi, Martin Emert, Amit Noheria, Rhea Pimentel, Rigoberto Ramirez, Y Madhu Reddy, Seth H Sheldon iD

Pacing and Clinical Electrophysiology · 2025

DOI: 10.1111/pace.70047 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pacing and Clinical Electrophysiology, 2025. Verfasst von Claire Sorensen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Education, University of Kansas School of Medicine, Kansas City, Kansas, USA. Hauptthemen laut MEDLINE: Atrial Fibrillation, Catheter Ablation, Persistent Left Superior Vena Cava. Die Arbeit nennt 15 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

A persistent left superior vena cava (PLSVC) can be a trigger for atrial fibrillation (AF).

Objective

We aimed to compare post‐ablation 1‐year freedom from recurrent atrial tachycardia (AT)/AF in PLSVC patients with a matched population without PLSVC (n‐PLSVC).

Methods

A single‐center, retrospective, case–control study between 2008 and 2022. Pre‐ablation imaging identified patients with PLSVC. Propensity score matching for age, sex, BMI, type of AF, AF ablation energy type, left atrial volume, and year of ablation was performed to identify five controls for each PLSVC patient. We excluded patients who had less than 1 year of follow‐up post‐ablation or underwent prior surgical ablation.

Results

There were 90 total patients including 15 PLSVC patients and 75 matched controls (60 ± 10 years old, 31% women, 58% paroxysmal, 62% radiofrequency). One‐year freedom from AF was lower with PLSVC (27%) than n‐PLSVC (59%, p = 0.02). The PLSVC was targeted for ablation in 5/15 patients (33%), all of whom had recurrent AT/AF within 1 year. Redo AF ablations were performed in 40% (6/15) of PLSVC patients. Freedom from AF at last follow‐up (median 2.1, IQR 0.5–4.0 years) was 83% in PLSVC patients who underwent redo ablation. The only complication was right atrial lead dysfunction post‐ablation requiring lead revision.

Conclusion

Although the post‐ablation freedom from AF is lower in patients with PLSVC than n‐PLSVC, repeat ablation can result in a high freedom from AF in patients with PLSVC. Further study is necessary to determine the optimal methods and role for PLSVC ablation (including the role for pulse‐field ablation).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationCatheter AblationPersistent Left Superior Vena CavaHumansFemaleMaleMiddle AgedRetrospective StudiesCase-Control StudiesTreatment OutcomeRecurrence

Stichwörter der Autor:innen

atrial fibrillationatrial fibrillation ablationpersistent left superior vena cava

Autor:innen und Institutionen

  • Department of Medical Education, University of Kansas School of Medicine, Kansas City, Kansas, USA.
  • Department of Cardiovascular Medicine, The University of Kansas Medical Center, Kansas City, Kansas, USA.
  • Department of Biostatistics and Data Science, University of Kansas School of Medicine, Kansas City, Kansas, USA.

ORCID-Profile: Claire Sorensen, Seth H Sheldon

Zitieren

APA

Sorensen, C., Shahab, A., Hu, J., Dendi, R., Emert, M., Noheria, A., Pimentel, R., Ramirez, R., Reddy, Y. M., & Sheldon, S. H. (2025). Impact of Persistent Left Superior Vena Cava on Outcomes With Atrial Fibrillation Ablation. Pacing and Clinical Electrophysiology. https://doi.org/10.1111/pace.70047

Vancouver

Sorensen C, Shahab A, Hu J, Dendi R, Emert M, Noheria A, et al. Impact of Persistent Left Superior Vena Cava on Outcomes With Atrial Fibrillation Ablation. Pacing and Clinical Electrophysiology. 2025. doi:10.1111/pace.70047

BibTeX
@article{Sorensen2025,
  author = {Sorensen, Claire and Shahab, Ahmed and Hu, Jinxiang and Dendi, Raghu and Emert, Martin and Noheria, Amit and Pimentel, Rhea and Ramirez, Rigoberto and Reddy, Y Madhu and Sheldon, Seth H},
  title = {Impact of Persistent Left Superior Vena Cava on Outcomes With Atrial Fibrillation Ablation},
  journal = {Pacing and Clinical Electrophysiology},
  year = {2025},
  doi = {10.1111/pace.70047}
}
Kostenlos starten →